HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sitagliptin/metformin (Janumet) for type 2 diabetes.

Authors
JournalThe Medical letter on drugs and therapeutics (Med Lett Drugs Ther) Vol. 49 Issue 1262 Pg. 45-7 (Jun 04 2007) ISSN: 1523-2859 [Electronic] United States
PMID17541377 (Publication Type: Journal Article)
Chemical References
  • Drug Combinations
  • Hypoglycemic Agents
  • Pyrazines
  • Triazoles
  • Metformin
  • Sitagliptin Phosphate
Topics
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Drug Combinations
  • Humans
  • Hypoglycemic Agents (administration & dosage, adverse effects, pharmacokinetics, therapeutic use)
  • Metformin (administration & dosage, adverse effects, pharmacokinetics, therapeutic use)
  • Pyrazines (administration & dosage, adverse effects, pharmacokinetics, therapeutic use)
  • Sitagliptin Phosphate
  • Treatment Outcome
  • Triazoles (administration & dosage, adverse effects, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: